11/18
01:19 pm
qnrx
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
01:29 pm
qnrx
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/11
09:27 am
qnrx
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies [Yahoo! Finance]
High
Report
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies [Yahoo! Finance]
11/11
08:30 am
qnrx
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
High
Report
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
11/7
01:15 am
qnrx
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
08:30 am
qnrx
Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results
High
Report
Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results
10/30
08:30 am
qnrx
Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Medium
Report
Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025
10/28
08:30 am
qnrx
Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study
Low
Report
Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study
10/21
08:30 am
qnrx
Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
High
Report
Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
10/10
10:56 am
qnrx
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million [Yahoo! Finance]
Medium
Report
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million [Yahoo! Finance]
10/10
09:24 am
qnrx
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
High
Report
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
9/9
08:51 am
qnrx
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome [Yahoo! Finance]
Low
Report
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome [Yahoo! Finance]
9/9
08:30 am
qnrx
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome
Low
Report
Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome